Effect of stellate ganglion block on intracranial vascular and stress level in patients with Moyamoya disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050015

Enrollment

Unknown

Registered

2021-08-15

Start date

2021-08-12

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moyamoya disease

Interventions

stellate ganglion group:1.5% lidocaine planetary ganglion block

control group:DSA only, no stellate ganglion block

Eligibility

Sex/Gender

All

Age

12 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. DSA cerebral angiography confirmed that the patient was a vascular malformation with specific changes in moyamoya disease; 2. Preoperative sober cooperation, can cooperate to complete all inspections and operations; 3. No known history of allergy to the test drug; 4. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. There is skin defect and infection at the neck puncture site; 2. Reviewer after EC-IC bypass operation.

Design outcomes

Primary

Measure	Time frame
diameter of superficial temporal artery;diameter of middle cerebral artery;	—

Secondary

Measure	Time frame
cortisol;	—

Countries

China

Contacts

Public ContactFeng Xia

the First Affiliated Hospital of Sun Yat-Sen University

fengxiar@aliyun.cn+86 13688877856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026